A detailed history of Deutsche Bank Ag\ transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 22,369 shares of NAUT stock, worth $51,001. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,369
Previous 32,691 31.57%
Holding current value
$51,001
Previous $97,000 32.99%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$2.41 - $3.18 $24,876 - $32,823
-10,322 Reduced 31.57%
22,369 $65,000
Q2 2023

Aug 14, 2023

SELL
$2.21 - $4.52 $19,240 - $39,351
-8,706 Reduced 21.03%
32,691 $126,000
Q1 2023

May 15, 2023

BUY
$1.67 - $2.77 $36,274 - $60,167
21,721 Added 110.39%
41,397 $114,000
Q4 2022

Feb 13, 2023

BUY
$1.55 - $2.47 $492 - $785
318 Added 1.64%
19,676 $35,000
Q3 2022

Nov 14, 2022

SELL
$1.96 - $3.13 $6,228 - $9,947
-3,178 Reduced 14.1%
19,358 $41,000
Q2 2022

Aug 11, 2022

BUY
$2.64 - $4.84 $59,495 - $109,074
22,536 New
22,536 $61,000

Others Institutions Holding NAUT

About Nautilus Biotechnology, Inc.


  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $284M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.